Skip to content
Connect Today UK

Users Coming Off Slimming Injections Regain Weight Four Times Faster Compared to People Using Diet and Exercise

Image of pharmaceutical syringe and scale
Obesity treatment involves ongoing approaches.

New research suggests that people who come off new GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who end conventional diet and exercise plans.

Published data in a prominent medical journal demonstrates that while obese people can lose about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"People buying such treatments should be cognizant of the danger of rapid weight regain when the therapy ends," cautioned researcher Dr. Susan Jebb.

This pace of recovery means a reversion to original weight in about a year and a half.

Analyzing Therapies

The study, which reviewed 37 of trials involving thousands of participants, compared the effects of these new drugs with older methods.

The team emphasize that individuals who lose weight through dieting usually see a less rapid creep back—perhaps 0.1 kg a month—after stopping.

The Reason for the Fast Rebound

Experts suggest the way of the injections explains the heightened regain.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement leads to hunger is uncontrolled, making binge eating a significant risk."

A Lifelong Disease?

Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, given the significant potential of weight regain, the therapy might need to be long-term.

This view is reinforced by drug manufacturers, who note that the results "underscore the long-term nature of excess weight," comparing it to managing diseases like diabetes.

User Experiences

Users who have discontinued the jabs describe a powerful return of hunger.

"I experienced a trigger flipping and you're instantly starving," recalled an individual.

The struggle is exacerbated if patients have not adopted sustainable lifestyle or habit changes during treatment.

Growing Adoption

Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.

  • Adoption is higher among women than men.
  • The middle-aged demographic shows the highest level of interest.
  • Many obtain the drugs through private prescriptions rather than the NHS.

Finally, researchers stress that while these medications are powerful tools for weight loss, they are not a magic solution and lasting health benefits likely depends on combined behavioural changes.

LA
Written by

Levi Allen

Eleanor is a relationship coach and writer exploring the art of connection in our fast-paced digital landscape.

Connect Today UK

Type to search articles.